Use of platelet function testing during dual antiplatelet therapy, including a P2Y12 antagonist, in acute coronary syndromes does not improve clinical outcomes. Researchers at King's College London ...

The MarketWatch News Department was not involved in the creation of this content. WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the ...

Despite no slam-dunk evidence supporting the use of guided dual antiplatelet therapy (DAPT) strategies, either with platelet function or genotype testing, a new review paper argues that there’s still ...

Use of platelet reactivity testing in ACS patients coming off P2Y12 inhibitors who may be at risk for perioperative bleeding can safely shorten the waiting time before CABG, potentially cutting ...

Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet ...

Medically reviewed by Doru Paul, MD Key Takeaways An MPV blood test measures the average size of your platelets to help assess blood health.High MPV means your body is making new platelets quickly ...

Patients with bleeding and clotting disorders living in low-income countries could benefit from new low-cost testing devices being developed at UWE Bristol. Researchers from the School of Applied ...